(VIANEWS) - Fortress Biotech (FBIOP), PBF Logistics LP (PBFX), John Hancock (HPF) have the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | Fortress Biotech (FBIOP) | 21.35 | -1.39% | 9.81% | 2022-03-22 15:23:21 |
| 2 | PBF Logistics LP (PBFX) | 14.09 | 0.93% | 8.6% | 2022-03-29 21:09:05 |
| 3 | John Hancock (HPF) | 18.37 | 0.11% | 8.02% | 2022-03-28 13:17:06 |
| 4 | ENI S.p.A. (E) | 29.69 | 1.52% | 5.11% | 2022-04-01 14:58:41 |
| 5 | Bank Nova Scotia Halifax (BNS) | 71.09 | -0.88% | 4.64% | 2022-04-01 14:52:52 |
| 6 | UNIVERSAL INSURANCE HOLDINGS (UVE) | 13.22 | -1.93% | 3.71% | 2022-03-31 03:15:13 |
| 7 | Lancaster Colony Corporation (LANC) | 154.85 | -0.67% | 2.09% | 2022-03-18 03:08:05 |
Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Fortress Biotech (FBIOP) - Dividend Yield: 9.81%
Fortress Biotech, Inc. is a biopharmaceutical firm that develops and markets pharmaceutical and biotech products. The company sells dermatology products such as Ximino capsules that treat only inflammatory lesion of moderate-to severe acne vulgaris (non-nodular), Targadox cream for severe ringworm, and Exelderm cream to manage jock itch symptoms. Ceracade is for dry skin conditions. Luxamend can be used to dress and manage wounds and Accutane capsules are for severe recalcitrant or nodular acne. The company also produces late-stage product candidates such as intravenous Tramadol to treat post-operative pain, CUTX101 and MB207 to treat X-linked severe combined immune deficiency, and Cosibelimab, which are used for patients suffering from EGFR mutations-positive NSCLC. MB102 is a blastic plasmacytoid cell neoplasm, MB101 for glioblastoma, MB104 for multiple myeloma. MB106 for B-cell NSCLC; CAEL-101 for the treatment of amyloid light chain amyloidosis. Triplex vaccine for cytomegalovirus; CEVA101 for severe traumatic brain injury in adults and children. Preclinical products include AAV-ATP7A gene treatment; AVTS-011 gene therapy; CK103 BET inhibitor, CEVAD and CEVA-102, CK-302 an anti-GITR, CK303 an anti–CAIX; ConVax, ONCOlogues and oligonucleotide platforms. There are collaboration agreements with universities and research institutes as well as pharmaceutical companies. The former name of the company was Coronado Biosciences, Inc., but it changed its name in April 2015 to Fortress Biotech, Inc. Fortress Biotech, Inc., was founded in 2006. It is located in New York, New York.
Volume
Today's last reported volume for Fortress Biotech is 8166, 47.84% below its average volume of 15656.
Fortress Biotech's last close was $21.61, 19.03% under its 52-week high of $26.69.
Fortress Biotech's Revenue
Year-on-year quarterly revenue growth grew by 122.5%, now sitting on 64.26M for the twelve trailing months.
Fortress Biotech's Stock Yearly Top and Bottom Value
Fortress Biotech's stock is valued at $21.35 at 20:15 EST, way below its 52-week high of $26.69 and way higher than its 52-week low of $18.96.
Fortress Biotech's Moving Average
Fortress Biotech's value is way under its 50-day moving average of $24.57 and way under its 200-day moving average of $25.54.More news about Fortress Biotech.
2. PBF Logistics LP (PBFX) - Dividend Yield: 8.6%
PBF Logistics LP is a company that owns and leases crude oil terminals and pipelines as well as other logistic assets. The company operates in Transportation and Terminaling, and Storage. Delaware City Refining Company LLC (DCR), a rail terminal with double loop tracks and ancillary pumps and unloading gear; the Toledo Truck Terminal is a crude truck unloading station; DCR West Rack, heavy crude oil rail unloading facilities at Delaware's refinery; the DCR Products Pipeline, interstate petroleum products pipeline; DCR Truck Rack, truck loading rack; San Joaquin Valley pipe system and Paulsboro natural gaz pipeline; and Knoxville Terminals which comprises two terminals for refined products terminals. The company is involved in receiving, handling and storage of oil, refined products and natural gas as well as intermediates. PBF Logistics LP's general partner is PBF Logistics GP LLC. It was established in 2012, and its headquarters are in Parsippany (New Jersey). PBF Logistics LP, a subsidiary to PBF Energy Inc.
Volume
Today's last reported volume for PBF Logistics LP is 81310, 58.86% below its average volume of 197632.
PBF Logistics LP's last close was $14.09, 15.63% below its 52-week high of $16.70.
PBF Logistics LP's Sales
PBF Logistics LP's sales growth is a negative 5.9% for the ongoing quarter and a decline by 6.6% for the next. The company's growth estimates for the current quarter is a negative 1.7% and positive 1.7% for the next.
PBF Logistics LP's Revenue
Year-on-year quarterly revenue growth grew by 0.3%, now sitting on 355.54M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,PBF Logistics LP's stock is considered to be oversold (<=20).
PBF Logistics LP's Stock Yearly Top and Bottom Value
PBF Logistics LP's stock is valued at $14.09 at 20:15 EST, way under its 52-week high of $16.70 and way higher than its 52-week low of $10.65.
PBF Logistics LP's Moving Average
PBF Logistics LP's value is higher than its 50-day moving average of $13.44 and higher than its 200-day moving average of $13.05.More news about PBF Logistics LP.
3. John Hancock (HPF) - Dividend Yield: 8.02%
John Hancock Preferred Income Fund 2 is a closed-ended fixed income mutual fund that was launched by John Hancock Investment Management LLC. John Hancock Asset Management co-manages the fund. It invests in fixed income markets within the United States. The fund seeks investments in securities from companies that operate across multiple sectors. It invests primarily in convertible preferred securities and preferred values of companies. The fund benchmarks its performance against both the Bank of America Merrill Lynch Hybrid Preferred Securities Index (Barclays U.S. Aggregate Bond Index. John Hancock Preferred Income Fund II, which was established on November 29, 2002, is based in the United States.
Volume
Today's last reported volume for John Hancock is 25938, 54.55% below its average volume of 57073.
John Hancock's last close was $18.35, 19.97% under its 52-week high of $22.93.
John Hancock's Revenue
Year-on-year quarterly revenue growth declined by 3%, now sitting on 36.52M for the twelve trailing months.
John Hancock's Stock Yearly Top and Bottom Value
John Hancock's stock is valued at $18.37 at 20:15 EST, way under its 52-week high of $22.93 and higher than its 52-week low of $17.47.
John Hancock's Moving Average
John Hancock's worth is below its 50-day moving average of $18.85 and way below its 200-day moving average of $20.96.More news about John Hancock.
4. ENI S.p.A. (E) - Dividend Yield: 5.11%
Eni S.p.A. is involved in exploration, development and production of natural oil and crude oil. Exploration & Production, Gas & Power, Refining & Marketing, and Chemical are its segments. It is also involved in field development and production, as well as LNG operations in 41 countries including the United Kingdom (UK), Angola and Congo, Nigeria and Mexico. The company also sells, trades, and supplies gas and electricity. It generates and exports oil. The company also engages in the petrochemicals industry, commodity risk management, asset-backed trading, and the production of various chemicals including olefins, aromatics, basic products, intermediate products, polystyrenes and elastomers in Italy and Western Europe. It is also involved in commodity trading, derivatives and other activities. Eni S.p.A., which was established in 1953, is located in Rome.
Volume
Today's last reported volume for ENI S.p.A. is 304749, 50.54% below its average volume of 616140.
ENI S.p.A.'s last close was $28.50, 12.47% under its 52-week high of $32.56.
ENI S.p.A.'s Revenue
Year-on-year quarterly revenue growth grew by 127%, now sitting on 77.77B for the twelve trailing months.
ENI S.p.A.'s Stock Yearly Top and Bottom Value
ENI S.p.A.'s stock is valued at $29.69 at 20:15 EST, below its 52-week high of $32.56 and way higher than its 52-week low of $21.91.
ENI S.p.A.'s Moving Average
ENI S.p.A.'s value is under its 50-day moving average of $29.93 and higher than its 200-day moving average of $27.13.More news about ENI S.p.A..
5. Bank Nova Scotia Halifax (BNS) - Dividend Yield: 4.64%
There are many banking services and products offered by the Bank of Nova Scotia in Canada, Mexico, Peru and Chile. They also offer international and domestic options. The Bank of Nova Scotia operates via the Canadian Banking, International Banking and Global Banking and Markets segments. It offers advice and solutions in financial matters, as well as day-to-day products such as debit and credit cards and chequing, saving, investing, mortgages and loans. The business bank solutions include lending, deposit, cash management and trade financing. The company also provides wealth management services, such as online brokerage, mobile investing, full-service brokerage and trust, private banking and private investment counseling. It also offers retail mutual funds and exchange traded funds. The company also offers international banking services to retail, commercial, and corporate clients; lending and transaction banking advisory services, capital markets access, and investment banking advisory services to corporate customers. It also offers telephone, internet, and mobile banking services. It has a total of approximately 950 branches, approximately 3650 automatic banking machines and 5500 ATMs in Canada. There are also approximately 1900 branches worldwide and contact centers. Toronto is the home of The Bank of Nova Scotia, which was established in 1832.
Volume
Today's last reported volume for Bank Nova Scotia Halifax is 3003560, 60.32% above its average volume of 1873490.
Bank Nova Scotia Halifax's last close was $71.72, 5.44% higher than its 52-week high of $68.02.
Bank Nova Scotia Halifax's Sales
Bank Nova Scotia Halifax's sales growth is 5.5% for the current quarter and 3.9% for the next. The company's growth estimates for the current quarter and the next is 3.1% and 3.8%, respectively.
Bank Nova Scotia Halifax's Revenue
Year-on-year quarterly revenue growth grew by 32.8%, now sitting on 28.28B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Bank Nova Scotia Halifax's stock is considered to be overbought (>=80).
Bank Nova Scotia Halifax's Stock Yearly Top and Bottom Value
Bank Nova Scotia Halifax's stock is valued at $71.09 at 20:15 EST, higher than its 52-week high of $68.02.
Bank Nova Scotia Halifax's Moving Average
Bank Nova Scotia Halifax's value is higher than its 50-day moving average of $65.31 and way higher than its 200-day moving average of $63.97.More news about Bank Nova Scotia Halifax.
6. UNIVERSAL INSURANCE HOLDINGS (UVE) - Dividend Yield: 3.71%
Universal Insurance Holdings, Inc., along with its subsidiary companies, is an integrated US insurance holding company. It markets and develops personal insurance products. This includes homeowners, renters/tenants and condo owners. The company also provides advice on actuarial matters, manages claims, underwrites policies, assists in reinsurance negotiations, places and manages the reinsurance programs; operates Clovered.com which allows consumers to receive quotes side-by-side from multiple carriers and educational material about homeowner's insurance policies. The company offers products via a network independent agents and Universal Direct, an online direct-to-consumer platform that allows homeowners to purchase, pay for and bind homeowner's policies. The original name of the company was Universal Heights, Inc., but it changed its name in 2001 to Universal Insurance Holdings, Inc. Universal Insurance Holdings, Inc. is an American company that was founded in 1990. Its headquarters are in Fort Lauderdale, Florida.
Volume
Today's last reported volume for UNIVERSAL INSURANCE HOLDINGS is 172429, 43.25% below its average volume of 303830.
UNIVERSAL INSURANCE HOLDINGS's last close was $13.22, 32.69% below its 52-week high of $19.64.
UNIVERSAL INSURANCE HOLDINGS's Sales
UNIVERSAL INSURANCE HOLDINGS's sales growth is 18.4% for the ongoing quarter and 20.4% for the next. The company's growth estimates for the current quarter is 140.5% and a drop 13.1% for the next.
UNIVERSAL INSURANCE HOLDINGS's Revenue
Year-on-year quarterly revenue growth grew by 7.2%, now sitting on 1.12B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,UNIVERSAL INSURANCE HOLDINGS's stock is considered to be overbought (>=80).
UNIVERSAL INSURANCE HOLDINGS's Stock Yearly Top and Bottom Value
UNIVERSAL INSURANCE HOLDINGS's stock is valued at $13.22 at 20:15 EST, way below its 52-week high of $19.64 and way higher than its 52-week low of $11.55.
UNIVERSAL INSURANCE HOLDINGS's Moving Average
UNIVERSAL INSURANCE HOLDINGS's value is below its 50-day moving average of $14.35 and under its 200-day moving average of $14.55.More news about UNIVERSAL INSURANCE HOLDINGS.
7. Lancaster Colony Corporation (LANC) - Dividend Yield: 2.09%
Lancaster Colony Corporation produces and markets food products in the United States. It operates two business segments: Retail and Foodservice. The company offers frozen Garlic Bread under New York BRAND Bakery. It also sells frozen Parkerhouse style yeast, dinner rolls, and dressings under Sister Schubert's. It also manufactures and distributes products under brand licensing agreements. These include Olive Garden dressings. Chick-fil A sauces. It sells products via food brokers and sales staff to restaurants and retailers. Lancaster Colony Corporation was established in 1961. It is located in Westerville in Ohio.
Volume
Today's last reported volume for Lancaster Colony Corporation is 49180, 48.85% below its average volume of 96154.
Lancaster Colony Corporation's last close was $154.85, 23.08% below its 52-week high of $201.31.
The company's growth estimates for the ongoing quarter and the next is a negative 14.1% and a negative 4.2%, respectively.Lancaster Colony Corporation's Revenue
Year-on-year quarterly revenue growth grew by 14.2%, now sitting on 1.56B for the twelve trailing months.
Lancaster Colony Corporation's Stock Yearly Top and Bottom Value
Lancaster Colony Corporation's stock is valued at $154.85 at 20:15 EST, way under its 52-week high of $201.31 and above its 52-week low of $145.79.
Lancaster Colony Corporation's Moving Average
Lancaster Colony Corporation's value is below its 50-day moving average of $160.84 and way below its 200-day moving average of $172.91.More news about Lancaster Colony Corporation.